Two Sigma Advisers’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Sell |
|
|||||
|
2025
Q1 | $3.21M | Sell |
|
|||||
|
2024
Q4 | $5.76M | Buy |
|
|||||
|
2024
Q3 | $6.75M | Buy |
|
|||||
|
2024
Q2 | $5.23M | Buy |
|
|||||
|
2024
Q1 | $5.95M | Buy |
|
|||||
|
2023
Q4 | $4.1M | Buy |
|
|||||
|
2023
Q3 | $3.1M | Sell |
|
|||||
|
2023
Q2 | $6.04M | Sell |
|
|||||
|
2023
Q1 | $6.4M | Buy |
|
|||||
|
2022
Q4 | $6.04M | Buy |
|
|||||
|
2022
Q3 | $2.4M | Buy |
|
|||||
|
2022
Q2 | $1.51M | Sell |
|
|||||
|
2022
Q1 | $2.12M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.77M | Sell |
|
|||||
|
2021
Q1 | $14.6M | Buy |
|
|||||
|
2020
Q4 | $8.88M | Buy |
|
|||||
|
2020
Q3 | $12.7M | Buy |
|
|||||
|
2020
Q2 | $1.38M | Buy |
|